MSC Exosomes vs Amniotic and Placental Exosomes: Understanding the Sources
Not all exosomes are the same. The source cell population shapes the vesicle population, which is why sourcing and characterization matter. This educational overview compares common sources.
Why source matters
Exosomes reflect the cells that produce them. A defined, screened source supports lot-to-lot consistency — documented by a per-lot Certificate of Analysis.
Common sources
- MSC-derived (e.g., Wharton’s jelly): from screened mesenchymal stem cells; widely studied in regenerative research.
- Amniotic / placental: derived from birth-tissue products; composition and characterization vary by preparation.
What to verify
Regardless of source, ask for characterization (particle size and concentration), sterility and endotoxin screening, and clear research-use-only labeling. Read more on MSC exosome research and browse the Exosome Research Library.
Sourcing
To discuss screened, documented, research-use MSC exosomes, partner with BioRegenEx.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical advice.
